{
    "Overall_score": {
        "Correlation": 9,
        "Sentiment": 7,
        "Importance": 8,
        "Impact": 6,
        "Duration": 5,
        "Virality": 3,
        "Source_Score": 6,
        "Specificity": 8,
        "Sector_Spread": 4,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "AMGN has advanced its 4th drug candidate for SHPT to Phase 3. Despite predictions of cashing out, the company continues to make progress. There is still more work ahead. #biotech #clinicaltrials",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 6,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        }
    ]
}